endocrinutri, Author at Endocrinutri - Ενδοκρινολόγος – Διαβητολόγος Κωνσταντίνος Μπουτσούρης - Ενδοκρινολογικό Ιατρείο Νέα Σμύρνη

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study; Azoulay L, Yin H, Filion KB, Assayag J, Majdan A, Pollak MN, Suissa S; British Medical Journal (BMJ) 344 e3645 (2012)

endocrinutri2020-01-29T13:40:47+00:00

OBJECTIVE To determine if the use of pioglitazone is associated [...]

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study; Azoulay L, Yin H, Filion KB, Assayag J, Majdan A, Pollak MN, Suissa S; British Medical Journal (BMJ) 344 e3645 (2012)endocrinutri2020-01-29T13:40:47+00:00

Relationship between HbA(1c) levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes; Andersson C, van Gaal L, Caterson ID, Weeke P, James WP, Cout

endocrinutri2020-01-29T13:40:02+00:00

AIMS/HYPOTHESIS: The optimal HbA(1c) concentration for prevention of macrovascular complications [...]

Relationship between HbA(1c) levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes; Andersson C, van Gaal L, Caterson ID, Weeke P, James WP, Coutendocrinutri2020-01-29T13:40:02+00:00

Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis; Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE; Journal of Clinical Endocrinology & Metabolism (Apr 2012)

endocrinutri2020-01-29T13:39:13+00:00

Context:Data on the potential effect of metformin on the risk [...]

Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis; Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE; Journal of Clinical Endocrinology & Metabolism (Apr 2012)endocrinutri2020-01-29T13:39:13+00:00

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis; Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessail

endocrinutri2020-01-29T13:38:33+00:00

OBJECTIVES: To update the evidence-based position statement published by the [...]

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis; Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailendocrinutri2020-01-29T13:38:33+00:00

Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?; Biondi B, Wartofsky L; Journal of Clinical Endocrinology & Metabolism (May 2012)

endocrinutri2020-01-29T13:37:16+00:00

Context:Levothyroxine therapy is the traditional lifelong replacement therapy for hypothyroid [...]

Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?; Biondi B, Wartofsky L; Journal of Clinical Endocrinology & Metabolism (May 2012)endocrinutri2020-01-29T13:37:16+00:00

Το διάστημα που είναι υπέρβαρη μια γυναίκα επηρεάζει τον κίνδυνο εμφάνισης καρκίνου
Το διάστημα που είναι υπέρβαρη μια γυναίκα επηρεάζει τον κίνδυνο εμφάνισης καρκίνου

Το διάστημα που είναι υπέρβαρη μια γυναίκα επηρεάζει τον κίνδυνο εμφάνισης καρκίνου

endocrinutri2020-01-29T13:36:38+00:00

Η έρευνα που παρακολούθησε σχεδόν 74.000 Αμερικανίδες ανακάλυψε ότι όσο [...]

Το διάστημα που είναι υπέρβαρη μια γυναίκα επηρεάζει τον κίνδυνο εμφάνισης καρκίνουendocrinutri2020-01-29T13:36:38+00:00

Staphylococcus aureus infections in pediatric patients with diabetes mellitus; Menne EN, Sonabend RY, Mason EO, Lamberth LB, Hammerman WA, Minard CG, Kaplan SL, Hulten KG; Journal of Infection and Chemotherapy (Apr 2012)

endocrinutri2020-01-29T13:35:21+00:00

OBJECTIVES: To describe Staphylococcus aureus infections in children with diabetes [...]

Staphylococcus aureus infections in pediatric patients with diabetes mellitus; Menne EN, Sonabend RY, Mason EO, Lamberth LB, Hammerman WA, Minard CG, Kaplan SL, Hulten KG; Journal of Infection and Chemotherapy (Apr 2012)endocrinutri2020-01-29T13:35:21+00:00

Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance; Celik O, Acbay O; Journal of Endocrinological Investigation (Apr 2012)

endocrinutri2020-01-29T13:34:38+00:00

Aim: We aimed to compare the effects of metformin and [...]

Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance; Celik O, Acbay O; Journal of Endocrinological Investigation (Apr 2012)endocrinutri2020-01-29T13:34:38+00:00

Insulin Versus GLP-1 Analogues in Poorly Controlled Type 2 Diabetic Subjects on Oral Therapy A Meta Analysis; Abdul-Ghani MA, Williams K, Kanat M, Altuntas Y, Defronzo RA; Journal of Endocrinological Investigation (Apr 2012)

endocrinutri2020-01-29T13:34:01+00:00

Aim: To compare insulin and GLP-1 analogues therapy on glycemic [...]

Insulin Versus GLP-1 Analogues in Poorly Controlled Type 2 Diabetic Subjects on Oral Therapy A Meta Analysis; Abdul-Ghani MA, Williams K, Kanat M, Altuntas Y, Defronzo RA; Journal of Endocrinological Investigation (Apr 2012)endocrinutri2020-01-29T13:34:01+00:00

Treatment of nonfunctioning pituitary adenomas: What were the contributions of the last 10years? A critical view; Pereira AM, Biermasz NR; Annales d’Endocrinologie (Apr 2012)

endocrinutri2020-01-29T13:33:24+00:00

Objectives.- All evidence for treatment and follow-up for nonfunctioning pituitary [...]

Treatment of nonfunctioning pituitary adenomas: What were the contributions of the last 10years? A critical view; Pereira AM, Biermasz NR; Annales d’Endocrinologie (Apr 2012)endocrinutri2020-01-29T13:33:24+00:00

About endocrinutri